Supplemented Very Low Protein Diet and the Progression of Chronic Kidney Disease
KETOPROG
Effect of Very Low Protein Diet Supplemented With Ketoanalogues of the Essential Amino Acids on the Progression of Chronic Kidney Disease
1 other identifier
interventional
250
1 country
1
Brief Summary
This is a prospective single center randomized controlled trial with a total duration of 18 months aiming to evaluate the effectiveness and the safety of a very low protein diet supplemented with ketoanalogues of essential aminoacids in reducing the progression of chronic kidney disease (CKD) in patients with advanced CKD.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Mar 2008
Longer than P75 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2008
CompletedFirst Submitted
Initial submission to the registry
January 7, 2014
CompletedFirst Posted
Study publicly available on registry
January 9, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedDecember 22, 2017
December 1, 2017
6.3 years
January 7, 2014
December 21, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary composite endpoint
Need for renal replacement therapy or an at least 50% reduction in the estimated glomerular filtration rate compared to randomization
15 months after randomization
Secondary Outcomes (16)
Secondary efficacy parameter
months 3-15 after randomization
Secondary outcome measure - nitrogen balance
15 months after randomization
Secondary efficacy parameter - mineral metabolism
15 weeks after randomization
Secondary efficacy parameter
15 weeks after randomization
Secondary efficacy parameter
15 weeks after randomization
- +11 more secondary outcomes
Other Outcomes (2)
Compliance - protein intake
18 months after enrolment
Compliance - energy intake
18 weeks after enrolment
Study Arms (2)
Keto-diet (KD)
EXPERIMENTALPatients in the intervention arm (KD group) will receive a vegetarian very low protein diet (0.3 g proteins/kg ideal body weight per day) supplemented with ketoanalogues of essential amino acids (Ketosteril®, Fresenius Kabi, Bad Homburg, Germany), 1 capsule for every 5 kg of ideal dry body weight per day.
Low Protein Diet group (LPD)
ACTIVE COMPARATORThe patients in the control arm (LPD group) will continue their conventional low protein diet, with 0.6 g/kg per day (including high biological value proteins). The total recommended energy intake is of 30 kcal/kg of ideal dry body weight per day in both arms.
Interventions
Eligibility Criteria
You may qualify if:
- adult non-diabetic patients
- stage 4-5 CKD not on dialysis (estimated glomerular filtration by Modification of Diet in Renal Disease formula \< 30 mL/min per year
- stable renal function at least 12 weeks before enrollment
- well-controlled arterial blood pressure
- proteinuria less than 1 g/g urinary creatinine
- good nutritional status
- declared and anticipated good compliance with the prescribed diet
You may not qualify if:
- poorly controlled arterial blood pressure (≥145/85 mm Hg)
- relevant comorbid conditions (diabetes mellitus, heart failure, active hepatic disease, digestive diseases with malabsorption, inflammation/anti-inflammatory therapy)
- uremic complications (pericarditis, polyneuropathy)
- feeding inability (anorexia, nausea)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
"Dr Carol Davila" Teaching Hospital of Nephrology
Bucharest, 010731, Romania
Related Publications (2)
Mircescu G, Garneata L, Stancu SH, Capusa C. Effects of a supplemented hypoproteic diet in chronic kidney disease. J Ren Nutr. 2007 May;17(3):179-88. doi: 10.1053/j.jrn.2006.12.012.
PMID: 17462550RESULTHahn D, Hodson EM, Fouque D. Low protein diets for non-diabetic adults with chronic kidney disease. Cochrane Database Syst Rev. 2020 Oct 29;10(10):CD001892. doi: 10.1002/14651858.CD001892.pub5.
PMID: 33118160DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Gabriel Mircescu, Prof
Carol Davila University of Medicine and Pharmacy
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Nephrology, MD, PhD
Study Record Dates
First Submitted
January 7, 2014
First Posted
January 9, 2014
Study Start
March 1, 2008
Primary Completion
June 1, 2014
Study Completion
August 1, 2014
Last Updated
December 22, 2017
Record last verified: 2017-12